Study about Ewing sarcoma used Anti-RRM2 polyclonal antibody
Article: "Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma"
Ewing’s sarcoma is a rare cancerous tumor that grows in the bones and in the soft tissue around the bones, such as cartilage or the nerves. It mostly affects children, adolescents, and young adults.
In this study, our anti-RRM2 polyclonal antibody (HPA056994) provides translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma.
Find out more about our Anti-RRM2 polyclonal antibody.